Semler Scientific, Inc.

Semler Scientific provides technology solutions to enhance healthcare providers effectiveness and efficiency. Products include QuantaFlo, a blood flow test for vascular condition examinations, and Insulin Insights, software for optimizing outpatient insulin dosing. Products serve various medical professionals, health insurance plans, and industry companies. Sales representatives and distributors offer the products. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Overview

Sector

Medical Devices

Target Price

0.9 USD

Current Price

33.8 USD

Potential

-97%

Strengths

Current Price to Earnings Ratio (8.21) is lower than the sector mean (123.56).
Price to book ratio (1.45) is lower than the sector mean (13.90).
The company has low debt. Net Debt to EBITDA Ratio is -0.41 and it is lower than the sector mean.
EV/EBIT (15.62) is lower than the sector mean.
Strong EBITDA Margin of 37.99%.

Weaknesses

With a depreciation Potential of -97.47%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.

Key Financial Data

Indicator	Value
PER	7.9
EV/EBITDA	14.7
Price/Free Cash Flow'	100.0
ROIC	10.6%
Net Debt/EBITDA	-0.4